Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Komajda

Showing results (1-10 of 277) with videos related to

Pageof 28
Sort By:
Archives of Cardiovascular Diseases|March 16, 2011
Heart rate decrease: a new paradigm in the treatment of heart failure. Insights from the SHIFT studyMichel Komajda
European Heart Journal|November 23, 2014
Heart rate in chronic heart failure: an overlooked risk factorMichel Komajda
Bulletin De L'Academie Nationale De Medecine|July 31, 2002
[Contribution of genetics to cardiomyopathy]Michel Komajda
Journal of the American College of Cardiology|February 20, 2007
Anemia in chronic heart failure: should we treat it and how?Michel Komajda
European Journal of Heart Failure|January 5, 2017
Liraglutide in heart failure: caution is neededMichel Komajda
Drugs of Today (Barcelona, Spain : 1998)|January 25, 2007
Improving outcomes in chronic heart failureMichel Komajda
Journal of Cardiac Failure|March 10, 2004
Prevalence of anemia in patients with chronic heart failure and their clinical characteristicsMichel Komajda
Kardiologia Polska|June 26, 2013
Novel approaches to heart rate modulation in chronic heart failureMichel Komajda
Heart Failure Monitor|March 14, 2003
Are angiotensin II receptor antagonists indicated in chronic heart failure?Michel Komajda
La Revue Du Praticien|December 5, 2018
Management of acute heart failureMichel Komajda
Pageof 28

Showing results (1-10 of 277) with videos related to

Sort By:
Pageof 28
Archives of Cardiovascular Diseases|March 16, 2011
Heart rate decrease: a new paradigm in the treatment of heart failure. Insights from the SHIFT studyMichel Komajda
European Heart Journal|November 23, 2014
Heart rate in chronic heart failure: an overlooked risk factorMichel Komajda
Bulletin De L'Academie Nationale De Medecine|July 31, 2002
[Contribution of genetics to cardiomyopathy]Michel Komajda
Journal of the American College of Cardiology|February 20, 2007
Anemia in chronic heart failure: should we treat it and how?Michel Komajda
European Journal of Heart Failure|January 5, 2017
Liraglutide in heart failure: caution is neededMichel Komajda
Drugs of Today (Barcelona, Spain : 1998)|January 25, 2007
Improving outcomes in chronic heart failureMichel Komajda
Journal of Cardiac Failure|March 10, 2004
Prevalence of anemia in patients with chronic heart failure and their clinical characteristicsMichel Komajda
Kardiologia Polska|June 26, 2013
Novel approaches to heart rate modulation in chronic heart failureMichel Komajda
Heart Failure Monitor|March 14, 2003
Are angiotensin II receptor antagonists indicated in chronic heart failure?Michel Komajda
La Revue Du Praticien|December 5, 2018
Management of acute heart failureMichel Komajda
Pageof 28